Laurion Capital Management LP Nurix Therapeutics, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$7.88 - $14.82 $224,343 - $421,925
-28,470 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$12.94 - $29.65 $368,401 - $844,135
28,470 New
28,470 $399,000
Q2 2021

Aug 13, 2021
SELL
$24.21 - $35.89 $169,470 - $251,230
-7,000 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$16.05 - $34.91 $112,350 - $244,369
7,000 New
7,000 $244,000

Others Institutions Holding NRIX

# of Institutions
180
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $940M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email